Formoterol Fumarate Inhalation Aerosol(Joincare Pharma)

富马酸福莫特罗吸入气雾剂(健康元药业)

Report date: 2025/08/18 17:05:06

Base Information

Drug NameFormoterol Fumarate Inhalation Aerosol(Joincare Pharma)
Drug Alias NameEformoterol fumarate福莫特罗延胡索酸盐formoterol富马酸福莫特罗formoterolum +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A